ArticleClinical case reports2025
Exploring Interstitial Pneumonia With Autoimmune Features: Case Study Insights and Review of Current Literature.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring Interstitial Pneumonia With Autoimmune Features: Case Study Insights and Review of Current Literature.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interstitial Pneumonia with Autoimmune Features (IPAF) refers to a subgroup of interstitial lung diseases that show autoimmune-like characteristics but do not align with established conditions such as idiopathic pulmonary fibrosis (IPF) or recognized connective tissue diseases (CTD). In this case report, we present a 43-year-old woman who had a history of dry cough, decreased appetite, weight loss, and progressive shortness of breath. Initial investigations, including spirometry, autoantibody testing, and CT scan, revealed evidence of nonspecific interstitial pneumonia and positive autoantibodies. Our patient did not fully meet the CTD criteria, and based on the clinical symptoms, imaging findings, and the presence of autoantibodies, an IPAF diagnosis was made. Our patient was treated with prednisolone and mycophenolate, significantly improving her symptoms, pulmonary function, and exercise capacity during the one-year follow-up period. Our report mentioned the importance of considering IPAF in the differential diagnosis of patients presenting with interstitial lung disease and features of an autoimmune process. Delayed diagnosis contributes to poorer prognoses and increased disease severity among affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.